SALL4 and hepatocellular carcinoma: Moreover, the association between a high CTA- and SALL4-specific T cell response and a low relapse rate of HCC at the 1-year follow-up further supports the potential protective role of the CTA- and SALL4-specific T cell response in early-stage HCC.